Yerkin Dunbayev1,2,†, Yen-Ju Chen3,†, Lorenzo Sassi4,5, Eun A Lee1, Jae Sun Ra1, Moonjung Choi1, Anirban Mukherjee6, Karen M. Vasquez6, Vincenzo Costanzo4,5, Peter Chi3,7,*, Kei-ichi Takata1,8,*
1Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea
2Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea
3Institute of Biochemical Sciences, National Taiwan University, Taipei 10617, Taiwan
4Department of Oncology and Hematology-Oncology, University of Milan, Via Adamello 16, Milan 20139, Italy
5IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy
6Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, 1400 Barbara Jordan Boulevard, Austin, TX 78723, United States
7Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan
8Department of Biomedical Engineering, College of Information-Bio Convergence Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea
∗To whom correspondence should be addressed. : Kei-ichi Takata
Correspondence may also be addressed to Peter Chi.
†The first two authors should be regarded as Joint First Authors.